804 related articles for article (PubMed ID: 10347103)
1. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
Benedetti A; Alvaro D; Bassotti C; Gigliozzi A; Ferretti G; La Rosa T; Di Sario A; Baiocchi L; Jezequel AM
Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446
[TBL] [Abstract][Full Text] [Related]
3. [Studies on pruritus in obstructive jaundice cases with special references to serum bile acid fractions].
Mashima H
Fukuoka Igaku Zasshi; 1991 Aug; 82(8):445-57. PubMed ID: 1937344
[TBL] [Abstract][Full Text] [Related]
4. Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function.
Güldütuna S; Leuschner M; Wunderlich N; Nickel A; Bhatti S; Hübner K; Leuschner U
Eur J Clin Pharmacol; 1993; 45(3):221-5. PubMed ID: 8276045
[TBL] [Abstract][Full Text] [Related]
5. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
Lindor KD; Lacerda MA; Jorgensen RA; DeSotel CK; Batta AK; Salen G; Dickson ER; Rossi SS; Hofmann AF
Am J Gastroenterol; 1998 Sep; 93(9):1498-504. PubMed ID: 9732932
[TBL] [Abstract][Full Text] [Related]
6. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment.
Chretien Y; Poupon R; Gherardt MF; Chazouilleres O; Labbe D; Myara A; Trivin F
Gut; 1989 Aug; 30(8):1110-5. PubMed ID: 2767508
[TBL] [Abstract][Full Text] [Related]
7. Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health.
Dilger K; Hohenester S; Winkler-Budenhofer U; Bastiaansen BA; Schaap FG; Rust C; Beuers U
J Hepatol; 2012 Jul; 57(1):133-40. PubMed ID: 22414767
[TBL] [Abstract][Full Text] [Related]
8. Changes in bile acid composition and effect on cytolytic activity of fecal water by ursodeoxycholic acid administration: a placebo-controlled cross-over intervention trial in healthy volunteers.
van Gorkom BA; van der Meer R; Boersma-van Ek W; Termont DS; de Vries EG; Kleibeuker JH
Scand J Gastroenterol; 2002 Aug; 37(8):965-71. PubMed ID: 12229974
[TBL] [Abstract][Full Text] [Related]
9. Effect of ursodeoxycholic acid administration on bile acid composition in hamster bile.
Matejka M; Vescina C; Carducci CN; Alayón A; Dios A; Scarlatto E; Mamianetti A
Pharmacol Res; 1990; 22(3):297-305. PubMed ID: 2367280
[TBL] [Abstract][Full Text] [Related]
10. Effect of 7-ketolithocholic acid on bile acid metabolism in humans.
Salen G; Verga D; Batta AK; Tint GS; Shefer S
Gastroenterology; 1982 Aug; 83(2):341-7. PubMed ID: 7084613
[TBL] [Abstract][Full Text] [Related]
11. Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy.
Poupon RE; Chrétien Y; Poupon R; Paumgartner G
Hepatology; 1993 Apr; 17(4):599-604. PubMed ID: 8477964
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis.
Mazzella G; Parini P; Bazzoli F; Villanova N; Festi D; Aldini R; Roda A; Cipolla A; Polimeni C; Tonelli D
Dig Dis Sci; 1993 May; 38(5):896-902. PubMed ID: 8482188
[TBL] [Abstract][Full Text] [Related]
13. Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment.
Batta AK; Arora R; Salen G; Tint GS; Eskreis D; Katz S
J Lipid Res; 1989 Dec; 30(12):1953-62. PubMed ID: 2621422
[TBL] [Abstract][Full Text] [Related]
14. Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate.
Rudolph G; Kloeters-Plachky P; Sauer P; Stiehl A
Eur J Clin Invest; 2002 Aug; 32(8):575-80. PubMed ID: 12190957
[TBL] [Abstract][Full Text] [Related]
15. Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response.
van de Meeberg PC; Wolfhagen FH; Van Berge-Henegouwen GP; Salemans JM; Tangerman A; van Buuren HR; van Hattum J; van Erpecum KJ
J Hepatol; 1996 Dec; 25(6):887-94. PubMed ID: 9007717
[TBL] [Abstract][Full Text] [Related]
16. Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps.
Batta AK; Salen G; Holubec H; Brasitus TA; Alberts D; Earnest DL
Cancer Res; 1998 Apr; 58(8):1684-7. PubMed ID: 9563483
[TBL] [Abstract][Full Text] [Related]
17. Ursocholic acid, a hydrophilic bile acid, fails to improve liver function parameters in primary biliary cirrhosis: comparison with ursodeoxycholic acid.
Batta AK; Salen G; Abroon J
Am J Gastroenterol; 1997 Jun; 92(6):1035-7. PubMed ID: 9177526
[TBL] [Abstract][Full Text] [Related]
18. Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis.
Roda E; Mazzella G; Bazzoli F; Villanova N; Minutello A; Simoni P; Ronchi M; Poggi C; Festi D; Aldini R
Dig Dis Sci; 1989 Dec; 34(12 Suppl):52S-58S. PubMed ID: 2598768
[TBL] [Abstract][Full Text] [Related]
19. Effect of ursodeoxycholic acid administration on biliary lipid composition and bile acid kinetics in cholesterol gallstone patients.
Roda E; Roda A; Sama C; Festi D; Mazzella G; Aldini R; Barbara L
Dig Dis Sci; 1979 Feb; 24(2):123-8. PubMed ID: 428300
[TBL] [Abstract][Full Text] [Related]
20. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]